Semaglutide reduces these inflammatory markers through multiple mechanisms: weight loss decreases fat tissue (a major source of inflammatory compounds), improved glucose control reduces glycation stress, and direct GLP-1 signaling in immune cells dampens pro-inflammatory pathways
Body weights were recorded at the start and at the end of the experiment
With more research, clearer answers will help people and doctors better understand the connection between semaglutide, weight loss, and sex drive
Semaglutide is offered in staged dosing, starting with the first-stage protocol and moving up under supervision
In the SURPASS-CVOT trial, people on dulaglutide lost approximately 5% of their body weight
[1] [2] Patients initiating Ozempic are generally advised to start at a low dose (0.25 mg weekly) with gradual titration every 4 weeks to therapeutic doses (0.5 mg, 1 mg, or 2 mg weekly) to minimise gastrointestinal side effects